Nitric oxide Messer 800 ppm v/v medicin. gas (compressed) gas cylinder Belgia - angielski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

nitric oxide messer 800 ppm v/v medicin. gas (compressed) gas cylinder

messer belgium sa-nv - nitric oxide 800 ppm v/v - medicinal gas, compressed - 800 ppm v/v - nitric oxide - nitric oxide

Liquid Medical Oxygen 100% Medicinal gas, cryogenic Irlandia - angielski - HPRA (Health Products Regulatory Authority)

liquid medical oxygen 100% medicinal gas, cryogenic

sol s.p.a. - oxygen - not assigned - 100 percent volume/volume - medical gases; oxygen

Liquid Medical Oxygen 100 % Medicinal gas, cryogenic Irlandia - angielski - HPRA (Health Products Regulatory Authority)

liquid medical oxygen 100 % medicinal gas, cryogenic

sol s.p.a. - oxygen - not assigned - 100 percent volume/volume - medical gases; oxygen

Medical Oxygen Irlandia - angielski - HPRA (Health Products Regulatory Authority)

medical oxygen

boc gases ireland ltd - oxygen - medicinal gas, compressed - 99.5 percent volume/volume - medical gases; oxygen

Placynox 50 % v/v - 50 % v/v medicin. gas (compressed) gas cylinder Belgia - angielski - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

placynox 50 % v/v - 50 % v/v medicin. gas (compressed) gas cylinder

messer belgium sa-nv - nitrous oxide 50 % v/v; oxygen 50 % v/v - medicinal gas, compressed - 50 % v/v - 50 % v/v - nitrous oxide 50 % v/v; oxygen 50 % v/v - nitrous oxide, combinations

Medical Helium Irlandia - angielski - HPRA (Health Products Regulatory Authority)

medical helium

boc gases ireland ltd - helium - medicinal gas, compressed - 99.5 percent volume/volume - medical gases; helium

INOmax nitric oxide 800 ppm medicinal gas for inhalation cylinder Australia - angielski - Department of Health (Therapeutic Goods Administration)

inomax nitric oxide 800 ppm medicinal gas for inhalation cylinder

ikaria australia pty ltd - nitric oxide, quantity: 0.08 % w/w - gas, medicinal - excipient ingredients: nitrogen - inomax?, in conjunction with ventilatory support and other appropriate agents, is indicated -,- for the treatment of term and near-term ( greater than 34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation.,- to selectively decrease pulmonary arterial pressure in patients with perioperative pulmonary hypertension in conjunction with heart surgery